Front Endocrinol (Lausanne)
September 2024
Objectives: Therapeutic options for pancreatic neuroendocrine neoplasia (Pan-NEN) have increased over the last decade. We aim to understand the evolution of the prognosis of patients with diagnosis of Pan-NEN within a 12-year period, considering the implementation of new treatments.
Methods: This study is a retrospective cohort study of patients diagnosed with Pan-NENs between 2006 and 2017.
Minerva Endocrinol (Torino)
December 2023
Background: Due to the low incidence and heterogeneous behavior of medullary thyroid carcinoma (MTC), its prognostic factors are still not well stablished. While several large studies have investigated the impact of gender in differentiated thyroid cancer (DTC), its role in MTC outcomes remains controversial. We aim to identify MTC prognostic features, specially focusing on the role of gender.
View Article and Find Full Text PDFIntroduction: Current guidelines specify controversial areas in adrenocortical carcinomas (ACC), such as optimal follow-up time after remission and identification of prognostic markers. We aim to address these topics by analyzing four reference centers in our country.
Methods: Cross-sectional multicentric study of 69 patients (mean age: 51.